{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:40:06Z","timestamp":1758573606355,"version":"3.44.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.tice.2021.101671","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T09:46:17Z","timestamp":1634895977000},"page":"101671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Therapeutic potential of mesenchymal stem cells for scleroderma induced in mouse model"],"prefix":"10.1016","volume":"73","author":[{"given":"Dina Fathy","family":"Elessawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala","family":"Gabr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9211-0009","authenticated-orcid":false,"given":"Monda Mohamed Maher","family":"Badawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer A.","family":"Gheita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tice.2021.101671_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13619-020-00058-0","article-title":"Mesenchymal stem cell as a novel approach to systemic sclerosis; current status and future perspectives","volume":"9","author":"Abedi","year":"2020","journal-title":"Cell Regen."},{"issue":"6","key":"10.1016\/j.tice.2021.101671_bib0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.matbio.2013.02.010","article-title":"Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies","volume":"32","author":"Agarwal","year":"2013","journal-title":"Matrix Biol."},{"key":"10.1016\/j.tice.2021.101671_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/IBPC.S232038","article-title":"Management of pulmonary arterial hypertension in patients with systemic sclerosis","volume":"13","author":"Almaaitah","year":"2020","journal-title":"Integr. Blood Press. Control"},{"key":"10.1016\/j.tice.2021.101671_bib0020","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2147\/TCRM.S219024","article-title":"Therapeutic challenges and advances in the management of systemic sclerosis-related pulmonary arterial hypertension (SSc-PAH)","volume":"15","author":"Argula","year":"2019","journal-title":"TherClin Risk Manag."},{"year":"2013","series-title":"Theory and Practice of Histological Techniques","author":"Bancroft","key":"10.1016\/j.tice.2021.101671_bib0025"},{"key":"10.1016\/j.tice.2021.101671_bib0030","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0092-8674(00)81270-2","article-title":"PDGF-A signaling is a critical event in lungalveolarmyofibroblasts development and alveogenesis","volume":"85","author":"Bostrom","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.tice.2021.101671_bib0035","doi-asserted-by":"crossref","DOI":"10.1177\/1179548420913281","article-title":"Patient and physician perspectives on systemic sclerosis-associated interstitial lung disease","volume":"14","author":"Cheema","year":"2020","journal-title":"Clin. Med. Insights Circ. Respir. Pulm. Med."},{"key":"10.1016\/j.tice.2021.101671_bib0040","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.3389\/fimmu.2018.02390","article-title":"Autologous hematopoietic stem cell transplantation for treatment of systemic sclerosis","volume":"9","author":"Del Papa","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.tice.2021.101671_bib0045","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5114\/reum.2020.99995","article-title":"Mesenchymal stem cells in systemic sclerosis therapy","volume":"58","author":"Dudek","year":"2020","journal-title":"Reumatologia"},{"issue":"3","key":"10.1016\/j.tice.2021.101671_bib0050","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00066-011-0046-3","article-title":"Radiation-induced changes in breathing frequency and lung histology of C57BL\/6 J mice are time- and dose-dependent","volume":"188","author":"Eldh","year":"2012","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.tice.2021.101671_bib0055","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0021-9258(17)31269-3","article-title":"Regulation of cell adhesion receptors by transforming growth factor-beta","volume":"264","author":"Heino","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.tice.2021.101671_bib0060","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/9\/3\/036007","article-title":"Increased exhaled nitric oxide precedes lung fibrosis in two murine models of systemic sclerosis","volume":"9","author":"Hua-Huy","year":"2015","journal-title":"J. Breath Res."},{"issue":"Suppl. 3","key":"10.1016\/j.tice.2021.101671_bib0065","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.5152\/eurjrheum.2020.19116","article-title":"Systemic sclerosis: to subset or not to subset, that is the question","volume":"7","author":"Johnson","year":"2020","journal-title":"Eur. J. Rheumatol."},{"issue":"6","key":"10.1016\/j.tice.2021.101671_bib0070","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1164\/rccm.201903-0563CI","article-title":"Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease","volume":"201","author":"Khanna","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.tice.2021.101671_bib0075","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1074\/jbc.270.7.3423","article-title":"Myofibroblasts from scleroderma skin synthesize elevatedlevels of collagen and tissue inhibitor of metalloproteinase(TIMP-1) with two forms of TIMP-1","volume":"270","author":"Kirk","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 3","key":"10.1016\/j.tice.2021.101671_bib0080","first-page":"iii14","article-title":"Skin disease: a cardinal feature of systemic sclerosis","volume":"48","author":"Krieg","year":"2009","journal-title":"Rheumatology"},{"issue":"suppl_5","key":"10.1016\/j.tice.2021.101671_bib0085","doi-asserted-by":"crossref","first-page":"v53","DOI":"10.1093\/rheumatology\/kex202","article-title":"Assessment of skin involvement in systemic sclerosis","volume":"56","author":"Kum\u00e1novics","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.tice.2021.101671_bib0090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00418-008-0519-3","article-title":"Isolation and characterization of Oct-4+\/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers","volume":"131","author":"La Rocca","year":"2009","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.tice.2021.101671_bib0095","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1083\/jcb.103.6.2403","article-title":"Enhanced production and extracellular deposition of the endothelial-type plasminogen activator in cultured human lung fibroblasts by transforming growth factor beta","volume":"103","author":"Laiho","year":"1986","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.tice.2021.101671_bib0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/art.30074","article-title":"CCN2 is required for bleomycin-induced skin fibrosis in mice","volume":"63","author":"Liu","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.tice.2021.101671_bib0105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.tice.2021.101671_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.02571","article-title":"Fibrosis development in HOCl-induced systemic sclerosis: a multistage process hampered by mesenchymal stem cells","volume":"9","author":"Maria","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.tice.2021.101671_bib0115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/niox.2000.0319","article-title":"A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite","volume":"5","author":"Miranda","year":"2001","journal-title":"Nitr. Oxide: Biol. Chem."},{"key":"10.1016\/j.tice.2021.101671_bib0120","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1016\/S0021-9258(18)68561-8","article-title":"Transforming growth factor b1 positivelyregulates its own expression in normal and transformedcells","volume":"263","author":"Obberghen-Schilling","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 125","key":"10.1016\/j.tice.2021.101671_bib0125","first-page":"3","article-title":"One year in review 2020: systemic sclerosis","volume":"38","author":"Orlandi","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.tice.2021.101671_bib0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13075-020-2140-3","article-title":"Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort","volume":"22","author":"Panopoulos","year":"2020","journal-title":"Arthritis Res. Ther."},{"issue":"84","key":"10.1016\/j.tice.2021.101671_bib0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/1523-1747.ep12274596","article-title":"Collagen biosynthesis in systemic scleroderma: regulation of posttranslational modifications and synthesis of procollagen in cultured fibroblasts","volume":"185","author":"Peltonen","year":"1985","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tice.2021.101671_bib0140","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3389\/fimmu.2018.02013","article-title":"Mesenchymal stromal cells based therapy in systemic sclerosis: rational and challenges","volume":"9","author":"Peltzer","year":"2018","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.tice.2021.101671_bib0145","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1093\/rheumatology\/keaa200","article-title":"Increased expression of the transforming growth factor beta-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target","volume":"59","author":"Piera-Velazquez","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.tice.2021.101671_bib0150","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1172\/JCI112950","article-title":"Transforming growth factor-b increases steady state levels of type I procollagen and fibronectin messenger RNAs post transcriptionally in cultured human dermal fibroblasts","volume":"79","author":"Raghow","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tice.2021.101671_bib0155","first-page":"419","article-title":"The transforming growth factorbs","volume":"vol. 95","author":"Roberts","year":"1990"},{"key":"10.1016\/j.tice.2021.101671_bib0160","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.3389\/fimmu.2018.02938","article-title":"Mesenchymal stem cells in systemic sclerosis: allogenic or autologous approaches for therapeutic use?","volume":"9","author":"Rozier","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2021.101671_bib0165","first-page":"585","article-title":"Smooth muscle differentiation in scleroderma fibroblastic cells","volume":"137","author":"Sappino","year":"1990","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tice.2021.101671_bib0170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2147\/OARRR.S228234","article-title":"Pulmonary arterial hypertension in systemic sclerosis: challenges in diagnosis, screening and treatment","volume":"11","author":"Saygin","year":"2019","journal-title":"Open Access Rheumatol."},{"issue":"4","key":"10.1016\/j.tice.2021.101671_bib0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5114\/reum.2019.87619","article-title":"Systemic sclerosis - multidisciplinary disease: clinical features and treatment","volume":"57","author":"Sobolewski","year":"2019","journal-title":"Reumatologia"},{"issue":"8","key":"10.1016\/j.tice.2021.101671_bib0180","first-page":"1361","article-title":"Pathogenic activation of mesenchymal stem cells is induced by the disease microenvironment in systemic sclerosis","volume":"72","author":"Taki","year":"2020","journal-title":"."},{"issue":"3","key":"10.1016\/j.tice.2021.101671_bib0185","doi-asserted-by":"crossref","first-page":"E121","DOI":"10.1016\/S2665-9913(20)30023-0","article-title":"Tackling systemic sclerosis from all angles","volume":"2","author":"The Lancet Rheumatology","year":"2020","journal-title":"Lancet Rheumatol."},{"issue":"5","key":"10.1016\/j.tice.2021.101671_bib0190","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/rheumatology\/kel451","article-title":"Skin involvement in scleroderma\u2014where histological and clinical scores meet","volume":"46","author":"Verrecchia","year":"2007","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.tice.2021.101671_bib0195","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/0019-5154.113930","article-title":"Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations","volume":"58","author":"Viswanath","year":"2013","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.tice.2021.101671_bib0200","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1186\/s40064-016-2774-4","article-title":"The protective effect of hydrogen sulfide on systemic sclerosis associated skin and lung fibrosis in mice model","volume":"5","author":"Wang","year":"2016","journal-title":"Springer Plus"},{"key":"10.1016\/j.tice.2021.101671_bib0205","article-title":"Classical disease-specific autoantibodies in systemic sclerosis: clinical features, gene susceptibility, and disease stratification","volume":"7","author":"Yang","year":"2020","journal-title":"Front Med (Lausanne)"}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816621001877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816621001877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:27:24Z","timestamp":1758572844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816621001877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":41,"alternative-id":["S0040816621001877"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2021.101671","relation":{},"ISSN":["0040-8166"],"issn-type":[{"type":"print","value":"0040-8166"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of mesenchymal stem cells for scleroderma induced in mouse model","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2021.101671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101671"}}